Status:
COMPLETED
Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Colon Cancer
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients receiving perioperative intravenous lidocaine, post operative restoration of bowel movement will be faster and decrease pain intensity, opioid consumption and side effects, length of hospital...
Detailed Description
The aim of this study is to assess whether perioperative intravenous lidocaine has an impact on the early postoperative physical activity recovery of patients scheduled for laparoscopic colorectal res...
Eligibility Criteria
Inclusion
- scheduled to undergo laparoscopic colorectal resection
Exclusion
- patients who have trouble to understand, read or communicate either in French or in English
- dementia
- patients suffering from severe physical disability (arthritis, neuromuscular dysfunction, stroke, paraplegia) or inability to walk or conduct daily activity
- patients suffering from severe cardiac or respiratory disease (status ASA IV
- patients suffering from metastatic carcinoma
- patients who have a history of chemoradiation within the six months preceding surgery
- allergy to lidocaine
- morbid obesity
- patients with chronic opioid use.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01155440
Start Date
June 1 2009
End Date
October 1 2011
Last Update
November 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MUHC
Montreal, Quebec, Canada, H3G1A4